BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 12559600)

  • 1. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.
    Vanizor Kural B; Orem A; Cimşit G; Yandi YE; Calapoglu M
    Clin Chim Acta; 2003 Feb; 328(1-2):71-82. PubMed ID: 12559600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease.
    Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M
    Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyslipidaemia & oxidative stress in patients of psoriasis: Emerging cardiovascular risk factors.
    Asha K; Singal A; Sharma SB; Arora VK; Aggarwal A
    Indian J Med Res; 2017 Dec; 146(6):708-713. PubMed ID: 29664028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.
    Orem C; Orem A; Uydu HA; Celik S; Erdöl C; Kural BV
    Coron Artery Dis; 2002 Feb; 13(1):65-71. PubMed ID: 11917201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.
    Orem A; Cimşit G; Değer O; Orem C; Vanizor B
    Clin Chim Acta; 1999 Jun; 284(1):81-8. PubMed ID: 10437645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients.
    Vanizor Kural B; Orem A; Cimşit G; Uydu HA; Yandi YE; Alver A
    Clin Chim Acta; 2003 Jun; 332(1-2):23-30. PubMed ID: 12763276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
    Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
    Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related modification of antioxidant enzyme activities in relation to cardiovascular risk factors.
    Fabian E; Bogner M; Elmadfa I
    Eur J Clin Invest; 2012 Jan; 42(1):42-8. PubMed ID: 21722101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein peroxidation in adult psoriatic patients.
    Offidani AM; Ferretti G; Taus M; Simonetti O; Dousset N; Valdiguie P; Curatola G; Bossi G
    Acta Derm Venereol Suppl (Stockh); 1994; 186():38-40. PubMed ID: 8073834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxidized LDL and lipids as risk factors for ischemic heart disease in type 2 diabetes].
    Zamaklar M; Lalić K; Rajković N; Trifunović D; Dragasević M; Popović L; Drasković D; Laić N; Jotić A; Vasović O; Lukić L; Milicić T; Potpara T
    Vojnosanit Pregl; 2005; 62(7-8):529-36. PubMed ID: 16171015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte antioxidant enzyme activities and lipid peroxidation in patients with types IIb and IV hyperlipoproteinemias.
    Efe H; Kirci D; Deger O; Yildirmis S; Uydu HA; Orem C
    Tohoku J Exp Med; 2004 Mar; 202(3):163-72. PubMed ID: 15065642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid peroxidation markers in Crohn's disease: the associations and diagnostic value.
    Boehm D; Krzystek-Korpacka M; Neubauer K; Matusiewicz M; Paradowski L; Gamian A
    Clin Chem Lab Med; 2012 Mar; 50(8):1359-66. PubMed ID: 22868800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of oxidized low-density lipoprotein in psoriatic skin and changes of plasma lipid levels in psoriatic patients.
    Tekin NS; Tekin IO; Barut F; Sipahi EY
    Mediators Inflamm; 2007; 2007():78454. PubMed ID: 17497039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of changes in antioxidant enzymes status in diabetic post menopausal group of women suffering from cardiovascular complications.
    Kumawat M; Sharma TK; Singh N; Ghalaut VS; Vardey SK; Sinha M; Kaushik GG
    Clin Lab; 2012; 58(3-4):203-7. PubMed ID: 22582492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlations between lipid ratio/oxidative stress status in COPD patients and pulmonary hypertension 
as well as prognosis].
    Li C; Yan L; Xu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Nov; 41(11):1168-1174. PubMed ID: 27932762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased neutrophil antioxidative enzyme activities and increased lipid peroxidation in hyperlipoproteinemic human subjects.
    Efe H; Değer O; Kirci D; Karahan SC; Orem A; Calapoğlu M
    Clin Chim Acta; 1999 Jan; 279(1-2):155-65. PubMed ID: 10064127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer.
    Badid N; Ahmed FZ; Merzouk H; Belbraouet S; Mokhtari N; Merzouk SA; Benhabib R; Hamzaoui D; Narce M
    Pathol Oncol Res; 2010 Jun; 16(2):159-67. PubMed ID: 19731090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
    Porkkala-Sarataho E; Nyyssönen K; Salonen JT
    Atherosclerosis; 1996 Jul; 124(1):83-94. PubMed ID: 8800496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihyperlipidaemic and hepatoprotective activities of acidic and enzymatic hydrolysis exopolysaccharides from Pleurotus eryngii SI-04.
    Zhang C; Li J; Wang J; Song X; Zhang J; Wu S; Hu C; Gong Z; Jia L
    BMC Complement Altern Med; 2017 Aug; 17(1):403. PubMed ID: 28806986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia].
    Broncel M; Koter-Michalak M; Chojnowska-Jezierska J
    Przegl Lek; 2006; 63(9):738-42. PubMed ID: 17479860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.